MDS classification is improving in an era of the WHO 2016 criteria of MDS: A population-based analysis among 9159 MDS patients diagnosed in the Netherlands-Reference-Cited by-同舟云学术

MDS classification is improving in an era of the WHO 2016 criteria of MDS: A population-based analysis among 9159 MDS patients diagnosed in the Netherlands

Published:2017-10 Issue: Volume:50 Page:137-140
ISSN:1877-7821
Container-title:Cancer Epidemiology
language:en
Short-container-title:Cancer Epidemiology

Author:

Dinmohamed Avinash G.^ORCID,Visser Otto,Posthuma Eduardus F.M.,Huijgens Peter C.,Sonneveld Pieter,van de Loosdrecht Arjan A.,Jongen-Lavrencic Mojca

Publisher

Elsevier BV

Subject

Cancer Research,Oncology,Epidemiology

Reference15 articles.

1. International scoring system for evaluating prognosis in myelodysplastic syndromes;Greenberg;Blood,1997

2. Revised international prognostic scoring system for myelodysplastic syndromes;Greenberg;Blood,2012

3. The 2016 revision to the World Health Organization classification of myeloid neoplasms and acute leukemia;Arber;Blood,2016

4. Diagnosis and treatment of primary myelodysplastic syndromes in adults: recommendations from the European LeukemiaNet;Malcovati;Blood,2013

5. Trends in incidence, initial treatment and survival of myelodysplastic syndromes: a population-based study of 5144 patients diagnosed in the Netherlands from 2001 to 2010;Dinmohamed;Eur. J. Cancer,2014

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Prevalence and treatment of anemia and secondary iron overload in patients with a myelodysplastic syndrome: Real-world data from a multicenter cohort study;Transfusion Clinique et Biologique;2023-08

2. High expression of miR-195 is related to favorable prognosis in cytogenetically normal acute myeloid leukemia;International Journal of Clinical Oncology;2021-08-09

3. Survey on Recommended Health Care for Adult Patients with Myelodysplastic Syndromes Identifies Areas for Improvement;International Journal of Environmental Research and Public Health;2020-12-21

4. Guideline-based indicators for adult patients with myelodysplastic syndromes;Blood Advances;2020-08-25